These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 4595253)
1. Comparison of ampicillin and nalidixic acid in the treatment of urinary tract infections caused by E. coli. Toivonen S; Pentikäinen P; Leirisalo M; Pyörälä K Acta Med Scand; 1974 Mar; 195(3):181-4. PubMed ID: 4595253 [No Abstract] [Full Text] [Related]
2. Nalidixic acid by intravenous infusion. A report of 50 cases. Economou G; Macis R; Ward-McQuaid N Br J Urol; 1972 Aug; 44(4):503-9. PubMed ID: 4560832 [No Abstract] [Full Text] [Related]
3. Extended therapy in patients with established urinary tract infection. Lawson DH; Gleadle RI; Linton AL Scott Med J; 1971 Mar; 16(3):169-72. PubMed ID: 4933924 [No Abstract] [Full Text] [Related]
4. Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women. Ahlmén J; Sigurdsson J; Wohrm A; Calmenius C; Merck C; Bucht H Scand J Infect Dis; 1983; 15(1):71-4. PubMed ID: 6342128 [TBL] [Abstract][Full Text] [Related]
5. The role of introital enterobacteria in recurrent urinary infections. Stamey TA Trans Am Assoc Genitourin Surg; 1972; 64():108-13. PubMed ID: 4569854 [No Abstract] [Full Text] [Related]
6. Nalidixic acid in urinary tract infections with particular reference to the emergence of resistance. Cederberg A; Denneberg T; Ekberg M; Juhlin I Scand J Infect Dis; 1974; 6(3):259-64. PubMed ID: 4607842 [No Abstract] [Full Text] [Related]
7. A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection. Bucy JG J Urol; 1981 Jun; 125(6):822-4. PubMed ID: 7017171 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections]. Yamasaki I; Kato T; Ogawa T Hinyokika Kiyo; 1965 Sep; 11(9):913-34. PubMed ID: 5324475 [No Abstract] [Full Text] [Related]
10. [Clinical use of Wintomylon (nalidixic acid) in the field of urology]. Gotoh K; Shinoda T; Ito S; Isogai K; Kimura T; Ohtani F; Ishiyama K Hinyokika Kiyo; 1965 Oct; 11(10):1011-4. PubMed ID: 5324357 [No Abstract] [Full Text] [Related]
11. Letter: Interaction of nalidixic acid and warfarin. Hoffbrand BI Br Med J; 1974 Jun; 2(5920):666. PubMed ID: 4600912 [No Abstract] [Full Text] [Related]
12. [Therapy results with nalidixic acid in chronic urinary tract infection]. Broghammer H Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373 [No Abstract] [Full Text] [Related]
14. Cephradine in urinary tract infections: a double-blind comparison with ampicillin. Low RA; Clarke TK Curr Med Res Opin; 1975; 3(4):211-7. PubMed ID: 1097196 [TBL] [Abstract][Full Text] [Related]
15. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections. Anderson K Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022 [No Abstract] [Full Text] [Related]
17. A clinical appraisal of nalidixic acid in urinary tract infection in childhood. Kneebone GM Med J Aust; 1965 Dec; 2(23):947-9. PubMed ID: 5321975 [No Abstract] [Full Text] [Related]
18. Nalidixic acid in urinary infection. Neogy KN; De MS; Chatterjee ML Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385 [No Abstract] [Full Text] [Related]
19. [Bacterial flora and current problems of resistence in urinary tract infections (author's transl)]. Peters HJ; Ludwig G; Ueberle W Med Klin; 1973 Sep; 68(39):1265-71. PubMed ID: 4201041 [No Abstract] [Full Text] [Related]